Abstract 2614: GlycoConnect™ ADC toolbox expansion with high DAR technology
Sign Up to like & getrecommendations! Published in 2024 at "Cancer Research"
DOI: 10.1158/1538-7445.am2024-2614
Abstract: Recently topoisomerase 1 inhibitors have gained significant traction as a cytotoxic payload for ADCs based on the clinical success of camptothecin-based ADCs Enhertu® (DXd) and Trodelvy® (SN-38). In contrast to the majority of other approved… read more here.
Keywords: technology; adc toolbox; glycoconnect adc; drug ... See more keywords